Genmab enters huge deal with Abbvie - gets DKK 5 billion in the bank
After a long hunt for a partner, Genmab has entered a deal with Abbvie over three antibody drugs, including epcoritamab. The deal has given Genmab an initial DKK 5 billion (USD 750 million) and can give them up to DKK 26 billion in total (USD 3.9 billion).
BY ELIZABETH MØNSTED JOHANSEN
Genmab didn't just find a partner for its drug candidate epcoritamab on Wednesday - its long hunt has also led to a deal for a further two antibodies.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
FDA approves former Genmab drug - royalties to follow
For abonnenter
